Cost-Effectiveness of LDL-C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States

Gandra, S.R., Villa, G., Fonarow, G.C. et al. (4 more authors) (2016) Cost-Effectiveness of LDL-C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States. Clinical Cardiology, 39 (6). pp. 313-320. ISSN 0160-9289

Abstract

Metadata

Authors/Creators:
  • Gandra, S.R.
  • Villa, G.
  • Fonarow, G.C.
  • Lothgren, M.
  • Lindgren, P.
  • Somaratne, R.
  • van Hout, B.
Copyright, Publisher and Additional Information: © 2016 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Dates:
  • Published: 20 June 2016
  • Accepted: 7 February 2016
  • Published (online): 19 April 2016
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 14 Nov 2016 11:58
Last Modified: 14 Nov 2016 11:58
Published Version: http://dx.doi.org/10.1002/clc.22535
Status: Published
Publisher: Wiley
Refereed: Yes
Identification Number: https://doi.org/10.1002/clc.22535

Share / Export

Statistics